- 4 updates
Owen Sharp, of the Prostate Cancer Charity, says the Abirateron drug allows prostate cancer patients to have "a full and active life."
The drug "improves the level of pain the men have...and means they can be full participants with their family and everyday activity at a time when they are coming towards the end of their life," he says.
A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.